Muutke küpsiste eelistusi

Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 1: Cardiovascular Diseases [Kõva köide]

  • Formaat: Hardback, 192 pages, kõrgus x laius: 229x152 mm, kaal: 550 g, 6 Tables, black and white
  • Ilmumisaeg: 13-Apr-2026
  • Kirjastus: Apple Academic Press Inc.
  • ISBN-10: 1779641907
  • ISBN-13: 9781779641908
Teised raamatud teemal:
  • Kõva köide
  • Hind: 144,00 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 192,00 €
  • Säästad 25%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 3-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Hardback, 192 pages, kõrgus x laius: 229x152 mm, kaal: 550 g, 6 Tables, black and white
  • Ilmumisaeg: 13-Apr-2026
  • Kirjastus: Apple Academic Press Inc.
  • ISBN-10: 1779641907
  • ISBN-13: 9781779641908
Teised raamatud teemal:

An in-depth look at the multifaceted and critical role of pharmacists in managing cardiovascular diseases, focusing hypertension, hyperlipidemia, angina, myocardial infarction, heart failure, arrhythmias, thrombosis, and shock. Presents the latest research, guidelines, and up-to-date best practices.



Recognizing that the value of pharmacists extends beyond clinical interventions to include cost-effective healthcare solutions and compassionate patient-centered care, this new series of handbooks showcases the expanded roles and responsibilities of pharmacists. It is the first of its kind to provide comprehensive information about evidence-based pharmacist care across a wide range of healthcare issues, providing the latest research, guidelines, and up-to-date best practices.

Volume 1: Cardiovascular Diseases

offers an in-depth look at the multifaceted and critical role pharmacists play in managing cardiovascular diseases, focusing on conditions such as hypertension, hyperlipidemia, angina, myocardial infarction, heart failure, arrhythmias, thrombosis, and shock.

VOLUMES IN HANDBOOKS OF EVIDENCE-BASED

Volume 1: Cardiovascular Diseases

Volume 2: Endocrine, Respiratory, and Renal Diseases and Disorders

Volume 3: Gastrointestinal Diseases and Disorders

Volume 4: Arthritis and Psychiatric Diseases and Disorders

Volume 5: System-Specific Infections

Volume 6: Widespread and Transmissible Infections

Volume 7: Skin Diseases and Conditions

Volume 8: Neurological, Hematological, and Urological Diseases and Disorders

Volume 9: Oncological Diseases and Disorders

Volume 10: Diseases and Disorders of Special Populations

Volume 11: Pharmacist Care in Special Services

Volume 12: Advanced Practices in Pharmacist Care

Volume 13: Pharmacist Skills and Competencies

Volume 14: Clinical Pharmacy, Advanced Pharmacist Practice, and Pharmacy Clinics: Case Studies from Around the World

1. Evidence-Based Pharmacist Care (Clinical, Economic, and Humanistic
Impact): Hypertension
2. Evidence-Based Pharmacist Care (Clinical, Economic,
and Humanistic Impact): Hyperlipidemia
3. Evidence-Based Pharmacist Care
(Clinical, Economic, and Humanistic Impact): Angina
4. Evidence-Based
Pharmacist Care (Clinical, Economic, and Humanistic Impact): Myocardial
Infarction
5. Evidence-Based Pharmacist Care (Clinical, Economic, and
Humanistic Impact): Arrhythmias
6. Evidence-Based Pharmacist Care (Clinical,
Economic, and Humanistic Impact): Thrombosis
7. Evidence-Based Pharmacist
Care (Clinical, Economic, and Humanistic Impact): Shock
Yaser Mohammed Al-Worafi, PhD, FRSPH (UK), is a Professor of Clinical Pharmacy at the College of Pharmacy, University of Science and Technology of Fujairah, United Arab Emirates. He has more than 20 years of experience in education, practice, research, and administration in Yemen, Saudi Arabia, United Arab Emirates, and Malaysia, having taught, prepared, designed, and written courses and programs for many universities on clinical pharmacy, pharmacy practice, social pharmacy, and patient care. He has authored over 100 peer-reviewed papers in international journals and book chapters and has edited more than 30 books. A fellow of the Royal Society of Public Health, UK, Prof. Yaser has been recognized globally for his contributions to pharmacy practice, education, and medication and patient safety and is listed as one of the Top 2% Scientists of the World by Stanford University. He is ranked among the best ten researchers globally in several key areas, highlighting his dedication and expertise in advancing medication safety and effectiveness.